| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/27/2015 | CA2563080C Monoclonal antibodies to hepatocyte growth factor |
| 01/27/2015 | CA2515699C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 01/27/2015 | CA2501653C Human anti-ifn-.gamma. neutralizing antibodies as selective ifn-.gamma. pathway inhibitors |
| 01/27/2015 | CA2488441C Synthetic antibody phage libraries |
| 01/27/2015 | CA2483285C Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 01/22/2015 | WO2015009831A2 Methods of treating urothelial carcinomas |
| 01/22/2015 | WO2015008070A1 Modulators |
| 01/22/2015 | WO2015007912A1 Methods and formulations which allow the modulation of immune responses related to the administration of a biopharmaceutical drug |
| 01/22/2015 | WO2015007887A1 Combination of a ligand of hvem and an immunotoxin for use in therapy |
| 01/22/2015 | WO2015007880A1 Antibodies recognizing the n-terminal part of tissue factor pathway inhibitor capable of eliciting pro-coagulant activity |
| 01/22/2015 | WO2015007727A1 Antibodies that bind urokinase plasminogen activator |
| 01/22/2015 | WO2015007542A1 Targeted modified il-1 family members |
| 01/22/2015 | WO2015007520A1 Targeting of cytokine antagonists |
| 01/22/2015 | WO2014190273A9 Chimeric antigen receptor-targeting monoclonal antibodies |
| 01/22/2015 | US20150025228 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 01/22/2015 | US20150025227 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 01/22/2015 | US20150025226 Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same |
| 01/22/2015 | US20150025225 Monoclonal antibody against el which inhibits enzyme activity of el |
| 01/22/2015 | US20150025224 Antagonists of neuropilin receptor function and use thereof |
| 01/22/2015 | US20150024484 Antibody Inhibitors of GDF-8 and Uses Thereof |
| 01/22/2015 | US20150024482 Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer |
| 01/22/2015 | US20150024459 Multivalent Antibody Complexes Targeting IGF-1R Show Potent Toxicity Against Solid Tumors |
| 01/22/2015 | US20150024458 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 01/22/2015 | US20150024457 Antibodies to troponin i and methods of use thereof |
| 01/22/2015 | US20150024434 METHOD FOR OBTAINING FAB FRAGMENTS FROM SINGLE ANTIBODY PRODUCING CELLS BY MULTIPLEXED CPR IN COMBINATION WITH TaqMan PROBES |
| 01/22/2015 | US20150024433 Humanized Antibodies That Recognize Alpha-Synuclein |
| 01/22/2015 | US20150024432 Methods for identifying immunobinders of cell-surface antigens |
| 01/22/2015 | US20150024413 Biomarkers of oxidative stress |
| 01/22/2015 | US20150023999 Novel Targets of Acinetobacter Baumannii |
| 01/22/2015 | US20150023988 Potent and selective inhibitors of nav1.7 |
| 01/22/2015 | US20150023987 Immunogenic compositions and reagents for preparing |
| 01/22/2015 | US20150023986 Modulation of Tim Receptor Activity in Combination with Cytoreductive Therapy |
| 01/22/2015 | US20150023985 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
| 01/22/2015 | US20150023982 Methods of administering anti-tnfalpha antibodies |
| 01/22/2015 | US20150023981 Method of treatment and agents useful for same |
| 01/22/2015 | US20150023980 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| 01/22/2015 | US20150023979 Antibodies Against E7 Protein of Human Papilloma Virus (HPV) |
| 01/22/2015 | US20150023978 Anti mif antibodies |
| 01/22/2015 | US20150023977 Protein formulations and methods of making same |
| 01/22/2015 | US20150023976 Antibody polypeptides that antagonize cd40l |
| 01/22/2015 | US20150023975 PAR-1 Activation by Metalloproteinase-1 (MMP-1) |
| 01/22/2015 | US20150023974 Toll-like receptor 2 binding epitope and binding member thereto |
| 01/22/2015 | US20150023972 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| 01/22/2015 | US20150023971 Modulation of Activity of Proneurotrophins |
| 01/22/2015 | US20150023970 Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy |
| 01/22/2015 | US20150023969 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 01/22/2015 | US20150023968 Compositions and methods for diagnosing and treating hyperthyroidism in companion animals |
| 01/22/2015 | US20150023967 Binding molecules for bcma and cd3 |
| 01/22/2015 | US20150023966 Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| 01/22/2015 | US20150023965 Methods of treating urothelial carcinoma |
| 01/22/2015 | US20150023964 FcgammaRIIB-Specific Antibodies and Methods of Use Thereof |
| 01/22/2015 | US20150023963 Method for the production of variable domains |
| 01/22/2015 | US20150023961 Methods of modulating immunological responses by administering truncated baff receptors |
| 01/22/2015 | US20150023959 Chimeric factor viii polypeptides and uses thereof |
| 01/22/2015 | US20150023958 Fusion polypeptide inhibiting vegf-c, vegf-d and/or angiopoietin-2, and use thereof |
| 01/22/2015 | US20150023957 Saa domain-specific antibodies and peptide antagonists and use thereof to treat inflammatory diseases |
| 01/22/2015 | US20150023956 Methods and compositions for increasing enzyme activity in the cns |
| 01/22/2015 | US20150023952 Anti-addl monoclonal antibody and uses thereof |
| 01/22/2015 | US20150023951 Anti-vegf antibodies |
| 01/22/2015 | US20150023949 Compositions and methods for diagnosis and treatment of pervasive developmental disorder |
| 01/22/2015 | US20150023920 Novel compositions and methods for preventing or treating cancer metastasis |
| 01/22/2015 | US20150023871 Compositions and methods for the diagnosis and treatment of tumor |
| 01/22/2015 | DE102013012146A1 Anti- Silizium - Antikõrper Anti silicon - antibodies |
| 01/21/2015 | EP2826791A2 Humanized anti-C5aR antibodies |
| 01/21/2015 | EP2826790A1 Gremlin-1 antibody |
| 01/21/2015 | EP2826789A1 Antibody constant region variant |
| 01/21/2015 | EP2825653A1 Generating targeted sequence diversity in fusion proteins |
| 01/21/2015 | EP2825561A1 Cell penetrating compositions for delivery of intracellular antibodies and antibody-like moieties and methods of use |
| 01/21/2015 | EP2825560A1 Bi-specific adapters |
| 01/21/2015 | EP2825559A2 Readily isolated bispecific antibodies with native immunoglobulin format |
| 01/21/2015 | EP2825558A2 Combination therapy for the treatment of ovarian cancer |
| 01/21/2015 | EP2825557A1 Soluble engineered monomeric fc |
| 01/21/2015 | EP2825553A1 Multispecific antigen-binding molecules and uses thereof |
| 01/21/2015 | EP2825197A1 Novel binding molecules with antitumoral activity |
| 01/21/2015 | EP2825037A1 Non-human animals expressing ph-sensitive immunoglobulin sequences |
| 01/21/2015 | EP2825036A1 Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same |
| 01/21/2015 | EP2825035A1 Mice that produce antigen-binding proteins with ph-dependent binding characteristics |
| 01/21/2015 | CN104302669A 抗cd98抗体及其使用方法 Antibodies and methods of using the anti-cd98 |
| 01/21/2015 | CN104302668A 双特异性的抗-egfr/抗igf-1r抗体 Bispecific anti -egfr / anti igf-1r antibody |
| 01/21/2015 | CN104302667A 外来体检测用单克隆抗体 Exosome detection with monoclonal antibodies |
| 01/21/2015 | CN104302666A 周围神经的IgG刺激髓鞘再生 IgG stimulation of peripheral nerve remyelination |
| 01/21/2015 | CN104302665A 与新生儿Fc受体的结合增强的变体Fc多肽 Binding to the neonatal Fc receptor-enhanced variant Fc polypeptide |
| 01/21/2015 | CN104302664A 多特异性抗原结合分子及其用途 Multispecific antigen-binding molecules and uses thereof |
| 01/21/2015 | CN104302320A 冻干以及水性抗cd40抗体制剂 Lyophilized antibody formulations and aqueous anti-cd40 |
| 01/21/2015 | CN104302171A 表达ph敏感性免疫球蛋白序列的非人动物 Ph sensitivity of non-human animals expressing immunoglobulin sequence |
| 01/21/2015 | CN104302170A 生产具有ph依赖性结合特性的抗原结合蛋白的小鼠 Producing a ph-dependent binding characteristics of an antigen binding protein in mice |
| 01/21/2015 | CN104302169A 组氨酸工程改造的轻链抗体和用于生成所述抗体的经基因修饰的非人动物 Histidine engineered light chain antibody and non-human animals used to generate the antibody genetically modified |
| 01/21/2015 | CN104293823A 可溶性i型鸭肝炎病毒3d蛋白的制备方法和应用 Preparation and application of i-type duck hepatitis virus soluble proteins 3d |
| 01/21/2015 | CN104293813A 皮肤剥脱综合征新的致病基因及其编码蛋白质和应用 Skin exfoliation syndrome and new disease genes encode proteins and application |
| 01/21/2015 | CN104293739A 针对h3n2犬流感病毒ha2蛋白的单克隆抗体 For h3n2 canine influenza virus monoclonal antibody protein ha2 |
| 01/21/2015 | CN104293738A 一种抗人FcεRⅠα亚基单克隆抗体及其应用 An anti-human monoclonal antibody and its application FcεRⅠα subunit |
| 01/21/2015 | CN104292335A 杂交瘤细胞株fq-b12、其产生的抗噻菌灵单克隆抗体及应用 Hybridoma cell line fq-b12, which produces anti thiabendazole and application of monoclonal antibodies |
| 01/21/2015 | CN104292334A 一种全人源抗ctla-4单克隆抗体、制备方法及应用 One kind of Human Anti ctla-4 monoclonal antibody preparation method and application |
| 01/21/2015 | CN104292333A 小鼠抗人prrt2单克隆抗体及其制备和应用 Prrt2 mouse anti-human monoclonal antibody and its preparation and application |
| 01/21/2015 | CN104292332A Cgrp抗体 Cgrp antibody |
| 01/21/2015 | CN104292331A 人源抗人α干扰素抗体及其应用 Human anti-human α-interferon antibody and its application |
| 01/21/2015 | CN104292330A 一种稳定性高的人源抗vegf抗体及其应用 Highly stable humanized anti-vegf antibody and its application |
| 01/21/2015 | CN104292329A 一种弓形虫致密颗粒蛋白6抗体的制备方法 A method for preparing dense granule protein 6 Toxoplasma antibodies |
| 01/21/2015 | CN103408660B 一种抗鼠疫杆菌f1抗原的单克隆抗体及其应用 An anti-f1 pestis antigen monoclonal antibody and its application |
| 01/21/2015 | CN103254308B H5亚型禽流感病毒血凝素蛋白的单克隆抗体或其结合活性片段及其用途 H5 subtype avian influenza virus hemagglutinin protein binding activity of monoclonal antibody or fragment and its use |